Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 179,516 | 181,099 | 168,923 | 187,253 | 168,573 |
| Cost of Goods | 34,278 | 40,866 | 34,306 | 39,886 | 38,864 |
| Gross Profit | 145,238 | 140,233 | 134,617 | 147,367 | 129,709 |
| Operating Expenses | 139,154 | 132,600 | 132,933 | 123,549 | 270,100 |
| Operating Income | 6,362 | 8,499 | 1,990 | 24,704 | -139,527 |
| Interest Expense | 4,279 | 4,695 | 4,580 | 4,680 | 4,689 |
| Other Income | 7,441 | -5,731 | 11,296 | 5,502 | 5,360 |
| Pre-tax Income | 9,524 | -1,927 | 8,706 | 25,526 | -138,856 |
| Income Tax | 4,092 | 2,920 | 3,894 | 9,485 | 4,610 |
| Net Income Continuous | 5,432 | -4,847 | 4,812 | 16,041 | -143,466 |
| Net Income | $5,432 | $-4,847 | $4,812 | $16,041 | $-143,466 |
| EPS Basic Total Ops | 0.12 | -0.11 | 0.10 | 0.36 | -3.11 |
| EPS Basic Continuous Ops | 0.12 | -0.11 | 0.10 | 0.35 | -3.11 |
| EPS Diluted Total Ops | 0.12 | -0.11 | 0.10 | 0.38 | -3.11 |
| EPS Diluted Continuous Ops | 0.12 | -0.11 | 0.10 | 0.41 | -3.11 |
| EPS Diluted Before Non-Recurring Items | 0.46 | 0.47 | 0.39 | 0.71 | 0.53 |
| EBITDA(a) | $28,235 | $36,693 | $24,025 | $46,815 | $-118,411 |